HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus.

Abstract
In contrast to chickens, there is a paucity of information on the potency of H5 vaccines to protect turkeys against the highly pathogenic avian influenza (HPAI) H5N1 virus infections. In this study, 4 groups, 10 turkey poults each, were vaccinated at seven days old with one of H5N2 or H5N1 commercial vaccines or one of two prepared H5N1 vaccines from a local Egyptian variant HPAI H5N1 (EGYvar/H5N1) strain. At 35 days age, all vaccinated and 10 non vaccinated birds were challenged intranasal with 10(6) EID(50)/0.1 ml of EGYvar/H5N1. All vaccines used in this study were immunogenic in turkeys. There was no cross reaction between the commercial vaccines and the Egyptian variant H5N1 antigen as obtained by the hemagglutination inhibition test. Birds vaccinated with H5N2 vaccine were died, while other H5N1 vaccinated groups have had 20-40% mortality. The highest virus excretion was found in non-vaccinated infected and H5N2 vaccinated birds. Eleven peculiar amino acid substitutions in H5 protein of the variant strain were existed neither in the vaccine strains nor in the earliest H5N1 virus introduced into Egypt in 2006. In conclusion, single vaccination at seven days old is inadequate for protection of meat turkeys against variant HPAI H5N1 challenge and multi-dose vaccination at older age is recommended. For the foreseeable future, continuous evaluation of the current vaccines in H5N1 endemic countries in the face of virus evolution is a paramount challenge to mitigate the socio-economic impact of the virus.
AuthorsWalid H Kilany, E M Abdelwhab, Abdel-Satar Arafa, Abdullah Selim, Marwa Safwat, Ahmed A Nawar, Ahmed M Erfan, Mohamed K Hassan, Mona M Aly, Hafez M Hafez
JournalVeterinary microbiology (Vet Microbiol) Vol. 150 Issue 1-2 Pg. 28-34 (May 12 2011) ISSN: 1873-2542 [Electronic] Netherlands
PMID21236607 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Adjuvants, Immunologic
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Influenza Vaccines
  • Vaccines, Inactivated
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Administration, Intranasal
  • Amino Acid Substitution
  • Animals
  • Egypt
  • Hemagglutination Inhibition Tests
  • Hemagglutinin Glycoproteins, Influenza Virus (genetics)
  • Influenza A Virus, H5N1 Subtype (immunology)
  • Influenza A Virus, H5N2 Subtype (immunology)
  • Influenza Vaccines (administration & dosage, immunology)
  • Influenza in Birds (immunology, prevention & control, virology)
  • Turkeys (immunology, virology)
  • Vaccination (veterinary)
  • Vaccines, Inactivated (immunology)
  • Virus Shedding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: